• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-26a-5p 的过表达通过靶向 DYRK1A 抑制阿尔茨海默病小鼠 Tau 磷酸化和 Aβ 积累。

Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.

机构信息

Department of Neurology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, 712000, China.

Department of Neurology, The First Affiliated Hospital of Xi'an Medical University, Xi'an City, Shaanxi Province, 710077, China.

出版信息

Curr Neurovasc Res. 2020;17(3):241-248. doi: 10.2174/1567202617666200414142637.

DOI:10.2174/1567202617666200414142637
PMID:32286945
Abstract

OBJECTIVE

It is reported that miR-26a-5p could regulate neuronal development, but its underlying mechanisms in Alzheimer's disease (AD) progression is unclear.

METHODS

APP (swe)/PS1 (ΔE9) transgenic mice served as AD mice. Morris water maze test was used to measure the spatial learning and memory ability of mice. The expressions of miR-26a-5p, DYRK1A, phosphorylated-Tau, Aβ40, and Aβ42 were detected. The relationship between miR- 26a-5p and DYRK1A was explored using dual luciferase reporter assay. The effects of miR-26a- 5p on AD mice was determined.

RESULTS

AD mice walked a lot of wrong ways to find the platform area and the latency time to reach the platform was longer. There was low expression of MiR-26a-5p in AD mice. Overexpression of miR-26a-5p inhibited Tau phosphorylation and Aβ accumulation. MiR-26a-5p negatively regulated DYRK1A via targeting its 3'UTR. In vivo, increased miR-26a-5p down-regulated Aβ40, Aβ42, p-APP and p-Tau levels in AD mice through decreasing DYRK1A. Meanwhile, the swimming path and the latency time, to reach the platform, was shorten after enhancing miR-26a-5p expression.

CONCLUSION

Overexpression of miR-26a-5p could repress Tau phosphorylation and Aβ accumulation via down-regulating DYRK1A level in AD mice.

摘要

目的

有报道称 miR-26a-5p 可调节神经元发育,但它在阿尔茨海默病(AD)进展中的潜在机制尚不清楚。

方法

APP(swe)/PS1(ΔE9)转基因小鼠作为 AD 小鼠。采用 Morris 水迷宫试验检测小鼠的空间学习和记忆能力。检测 miR-26a-5p、DYRK1A、磷酸化 Tau、Aβ40 和 Aβ42 的表达。采用双荧光素酶报告基因检测 miR-26a-5p 与 DYRK1A 之间的关系。探讨 miR-26a-5p 对 AD 小鼠的影响。

结果

AD 小鼠在寻找平台区域时走了很多错误的路,到达平台的潜伏期时间较长。AD 小鼠中 MiR-26a-5p 表达水平较低。过表达 miR-26a-5p 可抑制 Tau 磷酸化和 Aβ 积累。MiR-26a-5p 通过靶向 DYRK1A 的 3'UTR 负调控 DYRK1A。体内,通过降低 DYRK1A,增加的 miR-26a-5p 可降低 AD 小鼠中 Aβ40、Aβ42、p-APP 和 p-Tau 的水平,从而降低 Aβ40、Aβ42、p-APP 和 p-Tau 的水平。同时,增强 miR-26a-5p 表达后,小鼠的游泳路径和到达平台的潜伏期时间缩短。

结论

过表达 miR-26a-5p 可通过降低 DYRK1A 水平抑制 AD 小鼠 Tau 磷酸化和 Aβ 积累。

相似文献

1
Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.miR-26a-5p 的过表达通过靶向 DYRK1A 抑制阿尔茨海默病小鼠 Tau 磷酸化和 Aβ 积累。
Curr Neurovasc Res. 2020;17(3):241-248. doi: 10.2174/1567202617666200414142637.
2
MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.miR-335-5p 通过靶向 c-jun-N 末端激酶 3 抑制β-淀粉样蛋白(Aβ)积累,从而减轻阿尔茨海默病中的认知障碍。
Curr Neurovasc Res. 2020;17(1):93-101. doi: 10.2174/1567202617666200128141938.
3
microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing.miRNAs 的表达与唐氏综合征小鼠模型海马 APP、DYRK1A、过度磷酸化 Tau 和 BDNF 水平随年龄增长的相关性。
Neurosci Lett. 2020 Jan 1;714:134541. doi: 10.1016/j.neulet.2019.134541. Epub 2019 Oct 9.
4
miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.在阿尔茨海默病中,miR-219-5p通过靶向TTBK1和GSK-3β抑制tau蛋白磷酸化。
J Cell Biochem. 2019 Jun;120(6):9936-9946. doi: 10.1002/jcb.28276. Epub 2018 Dec 16.
5
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.唐氏综合征小鼠模型中 Dyrk1A 基因剂量的正常化可挽救几种阿尔茨海默病表型。
Neurobiol Dis. 2017 Oct;106:76-88. doi: 10.1016/j.nbd.2017.06.010. Epub 2017 Jun 21.
6
Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.长非编码 RNA 00507/miRNA-181c-5p/TTBK1/MAPT 轴调控阿尔茨海默病中 tau 的过度磷酸化。
J Gene Med. 2020 Dec;22(12):e3268. doi: 10.1002/jgm.3268. Epub 2020 Sep 23.
7
MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.miR-539-5p 通过调控 APP/PS1 双转基因小鼠的 PI3K/Akt/GSK-3β 通路减少淀粉样 β 蛋白生成、Tau 过度磷酸化和记忆损伤。
Neurotox Res. 2020 Aug;38(2):524-535. doi: 10.1007/s12640-020-00217-w. Epub 2020 May 15.
8
Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.微小 RNA-137 抑制阿尔茨海默病中的 Tau 过度磷酸化,并在转基因小鼠和人神经母细胞瘤 SH-SY5Y 细胞中靶向 CACNA1C 基因。
Med Sci Monit. 2018 Aug 13;24:5635-5644. doi: 10.12659/MSM.908765.
9
Dyrk1 inhibition improves Alzheimer's disease-like pathology.Dyrk1 抑制可改善阿尔茨海默病样病理。
Aging Cell. 2017 Oct;16(5):1146-1154. doi: 10.1111/acel.12648. Epub 2017 Aug 4.
10
MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer's disease mice via regulation of HMGB1/NF-κB signaling.miR-216a-5p 通过调控 HMGB1/NF-κB 信号改善阿尔茨海默病小鼠的学习记忆障碍和神经炎症反应。
Brain Res. 2021 Sep 1;1766:147511. doi: 10.1016/j.brainres.2021.147511. Epub 2021 May 4.

引用本文的文献

1
miR-26a-5p/ADAM17-Mediated Proteolysis of TREM2 Regulates Neuroinflammation in Hypertensive Mice Following Lead Exposure.miR-26a-5p/ADAM17介导的TREM2蛋白水解调节铅暴露后高血压小鼠的神经炎症
Toxics. 2025 Jan 5;13(1):37. doi: 10.3390/toxics13010037.
2
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease.miR-26a 是人类疾病诊断和预后的关键治疗靶点,具有巨大的潜力。
Curr Med Chem. 2024;31(18):2550-2570. doi: 10.2174/0109298673271808231116075056.
3
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.
死亡相关蛋白激酶 1 作为阿尔茨海默病的治疗靶点。
Transl Neurodegener. 2024 Jan 9;13(1):4. doi: 10.1186/s40035-023-00395-5.
4
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.miRNAs 在阿尔茨海默病发病机制、诊断和治疗中的潜在意义。
Int J Mol Sci. 2023 Nov 13;24(22):16259. doi: 10.3390/ijms242216259.
5
Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer's Disease.非编码RNA在阿尔茨海默病小胶质细胞激活和神经炎症中的作用
J Inflamm Res. 2023 Sep 21;16:4165-4211. doi: 10.2147/JIR.S422114. eCollection 2023.
6
The role of microRNAs in neurobiology and pathophysiology of the hippocampus.微小RNA在海马体神经生物学和病理生理学中的作用。
Front Mol Neurosci. 2023 Sep 4;16:1226413. doi: 10.3389/fnmol.2023.1226413. eCollection 2023.
7
Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia.血浆外泌体 lncRNA-miRNA-mRNA 网络构建及其在首发精神分裂症中的诊断效能鉴定。
BMC Psychiatry. 2023 Aug 21;23(1):611. doi: 10.1186/s12888-023-05052-9.
8
[Mechanism of miR-26a-5p/cAMP response element binding protein 1 molecular axis regulating osteogenic differentiation of adipose-derived mesenchymal stem cells].[微小RNA-26a-5p/环磷酸腺苷反应元件结合蛋白1分子轴调控脂肪间充质干细胞成骨分化的机制]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 May 15;37(5):615-621. doi: 10.7507/1002-1892.202211037.
9
Exploiting machine learning models to identify novel Alzheimer's disease biomarkers and potential targets.利用机器学习模型识别新型阿尔茨海默病生物标志物和潜在靶点。
Sci Rep. 2023 Mar 27;13(1):4979. doi: 10.1038/s41598-023-30904-5.
10
miR-26a-5p alleviates CFA-induced chronic inflammatory hyperalgesia through Wnt5a/CaMKII/NFAT signaling in mice.miR-26a-5p 通过 Wnt5a/CaMKII/NFAT 信号通路缓解 CFA 诱导的慢性炎症性痛觉过敏反应。
CNS Neurosci Ther. 2023 May;29(5):1254-1271. doi: 10.1111/cns.14099. Epub 2023 Feb 8.